SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-22-000099
Filing Date
2022-11-03
Accepted
2022-11-03 16:00:47
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K goss-20221103.htm   iXBRL 8-K 40995
2 EX-99.1 goss-20221103xexx991.htm EX-99.1 64071
6 gossamerbio-logoxrega.jpg GRAPHIC 150783
  Complete submission text file 0001728117-22-000099.txt   456536

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20221103.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20221103_lab.xml EX-101.LAB 23924
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20221103_pre.xml EX-101.PRE 12606
8 EXTRACTED XBRL INSTANCE DOCUMENT goss-20221103_htm.xml XML 10823
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 221357789
SIC: 2834 Pharmaceutical Preparations